Clinical Trial Update: ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for ATX-101 in advanced dedifferentiated liposarcoma and leiomyosarcoma has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyosarcoma
• Liposarcoma

Drugs mentioned

• ATX-101 (Deoxycholic acid)

Snippet

Sponsor: Benjamin Izar | Conditions: Leiomyosarcoma, Liposarcoma | Phase 2 | Status: TERMINATED | Results posted: 2023-12-06